Cite
HARVARD Citation
Gudiol, C. et al. (2021). Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?. Lancet. 8 (3), pp. e216-e228. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gudiol, C. et al. (2021). Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?. Lancet. 8 (3), pp. e216-e228. [Online].